Bisoprolol Fumarate and Hydrochlorothiazide

Product NDC: 10135-742
11-digit product format: 101350742
Labeler code: 10135
Product ID: 10135-742_3f7bca13-71ae-c3ed-e063-6294a90ac734
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Bisoprolol Fumarate and Hydrochlorothiazide
Dosage form: TABLET
Route: ORAL
Labeler: Marlex Pharmaceuticals, Inc.
Application: ANDA215562
Marketing category: ANDA
Marketing start: 2022-05-01
Substance: BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE
Active strength: 10; 6.25 mg/1; mg/1
Pharmacologic classes: Adrenergic beta-Antagonists [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS], beta-Adrenergic Blocker [EPC]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 44.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	Approval date
A215562-001	BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE	BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE	2.5MG;6.25MG	TABLET / ORAL	AB	2021-11-04
A215562-002	BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE	BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE	5MG;6.25MG	TABLET / ORAL	AB	2021-11-04
A215562-003	BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE	BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE	10MG;6.25MG	TABLET / ORAL	AB	2021-11-04

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-product	TE code
A215562-001	AB
A215562-002	AB
A215562-003	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 108 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-10-15 13:18:30	2026-09	A215562-001	BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE	2.5MG;6.25MG	TABLET / ORAL	AB	2021-11-04	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	A215562-002	BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE	5MG;6.25MG	TABLET / ORAL	AB	2021-11-04	`c2088c7a36db…`
2026-10-15 13:18:30	2026-09	A215562-003	BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE	10MG;6.25MG	TABLET / ORAL	AB	2021-11-04	`c2088c7a36db…`
2026-09-14 22:38:34	2026-08	A215562-001	BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE	2.5MG;6.25MG	TABLET / ORAL	AB	2021-11-04	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A215562-002	BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE	5MG;6.25MG	TABLET / ORAL	AB	2021-11-04	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A215562-003	BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE	10MG;6.25MG	TABLET / ORAL	AB	2021-11-04	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A215562-001	BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE	2.5MG;6.25MG	TABLET / ORAL	AB	2021-11-04	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A215562-002	BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE	5MG;6.25MG	TABLET / ORAL	AB	2021-11-04	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A215562-003	BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE	10MG;6.25MG	TABLET / ORAL	AB	2021-11-04	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A215562-001	BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE	2.5MG;6.25MG	TABLET / ORAL	AB	2021-11-04	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A215562-002	BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE	5MG;6.25MG	TABLET / ORAL	AB	2021-11-04	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A215562-003	BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE	10MG;6.25MG	TABLET / ORAL	AB	2021-11-04	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A215562-001	BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE	2.5MG;6.25MG	TABLET / ORAL	AB	2021-11-04	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A215562-002	BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE	5MG;6.25MG	TABLET / ORAL	AB	2021-11-04	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A215562-003	BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE	10MG;6.25MG	TABLET / ORAL	AB	2021-11-04	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A215562-001	BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE	2.5MG;6.25MG	TABLET / ORAL	AB	2021-11-04	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A215562-002	BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE	5MG;6.25MG	TABLET / ORAL	AB	2021-11-04	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A215562-003	BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE	10MG;6.25MG	TABLET / ORAL	AB	2021-11-04	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A215562-001	BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE	2.5MG;6.25MG	TABLET / ORAL	AB	2021-11-04	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A215562-002	BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE	5MG;6.25MG	TABLET / ORAL	AB	2021-11-04	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A215562-003	BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE	10MG;6.25MG	TABLET / ORAL	AB	2021-11-04	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A215562-001	BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE	2.5MG;6.25MG	TABLET / ORAL	AB	2021-11-04	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A215562-002	BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE	5MG;6.25MG	TABLET / ORAL	AB	2021-11-04	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A215562-003	BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE	10MG;6.25MG	TABLET / ORAL	AB	2021-11-04	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A215562-001	BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE	2.5MG;6.25MG	TABLET / ORAL	AB	2021-11-04	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A215562-002	BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE	5MG;6.25MG	TABLET / ORAL	AB	2021-11-04	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A215562-003	BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE	10MG;6.25MG	TABLET / ORAL	AB	2021-11-04	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A215562-001	BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE	2.5MG;6.25MG	TABLET / ORAL	AB	2021-11-04	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A215562-002	BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE	5MG;6.25MG	TABLET / ORAL	AB	2021-11-04	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A215562-003	BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE	10MG;6.25MG	TABLET / ORAL	AB	2021-11-04	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A215562-001	BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE	2.5MG;6.25MG	TABLET / ORAL	AB	2021-11-04	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A215562-002	BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE	5MG;6.25MG	TABLET / ORAL	AB	2021-11-04	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A215562-003	BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE	10MG;6.25MG	TABLET / ORAL	AB	2021-11-04	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A215562-001	BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE	2.5MG;6.25MG	TABLET / ORAL	AB	2021-11-04	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A215562-002	BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE	5MG;6.25MG	TABLET / ORAL	AB	2021-11-04	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A215562-003	BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE	10MG;6.25MG	TABLET / ORAL	AB	2021-11-04	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A215562-001	BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE	2.5MG;6.25MG	TABLET / ORAL	AB	2021-11-04	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A215562-002	BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE	5MG;6.25MG	TABLET / ORAL	AB	2021-11-04	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A215562-003	BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE	10MG;6.25MG	TABLET / ORAL	AB	2021-11-04	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A215562-001	BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE	2.5MG;6.25MG	TABLET / ORAL	AB	2021-11-04	`79d66fd596c7…`

Observed Orange Book normalized TE history#

Normalized TE history page 2 of 3 · 108 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A215562-002	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A215562-003	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A215562-001	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A215562-002	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A215562-003	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A215562-001	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A215562-002	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A215562-003	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A215562-001	AB	1	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A215562-002	AB	1	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A215562-003	AB	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A215562-001	AB	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A215562-002	AB	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A215562-003	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A215562-001	AB	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A215562-002	AB	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A215562-003	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A215562-001	AB	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A215562-002	AB	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A215562-003	AB	1	`4b0b4de00fa7…`
2022-03-09 01:35 UTC	2022-03	A215562-001	AB	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A215562-002	AB	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A215562-003	AB	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A215562-001	AB	1	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A215562-002	AB	1	`782e0a99824c…`
2021-12-28 21:50 UTC	2021-12	A215562-003	AB	1	`782e0a99824c…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A215562-001	AB	1	`6a51e52b5d6a…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A215562-002	AB	1	`6a51e52b5d6a…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A215562-003	AB	1	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A215562-001	AB	1	`1c564ffb4f44…`
2024-02-18 07:12 UTC	2024-02	A215562-002	AB	1	`1c564ffb4f44…`
2024-02-18 07:12 UTC	2024-02	A215562-003	AB	1	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A215562-001	AB	1	`ea1830bbd6c7…`
2023-12-20 04:57 UTC	2023-12	A215562-002	AB	1	`ea1830bbd6c7…`
2023-12-20 04:57 UTC	2023-12	A215562-003	AB	1	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A215562-001	AB	1	`a72a2bbeb626…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A215562-002	AB	1	`a72a2bbeb626…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A215562-003	AB	1	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A215562-001	AB	1	`9b2671bbb829…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A215562-002	AB	1	`9b2671bbb829…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product: Yes
Brand name base: Bisoprolol Fumarate and Hydrochlorothiazide
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
BISOPROLOL FUMARATE	10 mg/1
HYDROCHLOROTHIAZIDE	6.25 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
UR59KN573L	Internal UNII lookup
0J48LPH2TH	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 3 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
854908	Internal RxNorm lookup
854916	Internal RxNorm lookup
854919	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
df881501-42ae-624a-e053-2995a90ab2a0	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
c19ec24d-2c40-4b8d-7c20-500ffa3660a1	Product name	3	20260303
97e4a60d-917d-ef62-dc8a-bd557b62b708	Product name	7	20260129
1199f4b7-b537-466c-9a1c-cb09131e9f8b	Product name	1	20251117
e1a63b6e-1877-c2c1-01a3-03ea2817aa6f	Product name	3	20251027
b15e9aa6-d523-ca97-480e-570e0543a342	Product name	4	20251024
96816964-c075-ffa7-b7b8-d8570411a3b9	Product name	7	20250305
162cbc9d-ecc3-72ba-af9f-c76e2756ef54	Product name	3	20221207
9b303cd4-3186-2454-5706-3137e8b2dfd2	Product name	4	20221110
47fc2fe9-7afb-4be9-989d-787aaa6ad0ea	Product name	1	20200505
a8e65197-7914-7acf-c7ec-914d53819b34	Product name	3	20190624
8b67f333-47d1-8464-7ce4-406d3dbb295f	Product name	7	20190618
89a57420-ab44-5323-14f9-595159145f9b	Product name	2	20190612
c27b049d-3258-48cf-ebe5-08c236ae78e2	Product name	3	20190610
00fc2cf9-672f-3e0b-6afa-43cbc864d058	Product name	4	20180613
15b375b1-89c7-9594-80df-5a8c8864aee0	Product name	3	20180108
a7349398-661d-d9fc-46df-7e128bbd61d9	Product name	5	20171113
1bdb87cf-9b1f-6a51-5eb7-d182aaffaa3d	Product name	2	20170719
e0eeb018-194e-4b70-a57d-bac47a97b8ea	Product name	1	20160825
55bffd21-17e1-ff02-2e8f-1f9a532b9502	Product name	2	20150320
ea069444-e874-4c28-833f-d2f52734ef4d	Product name	1	20150206
041df61b-f8b6-48a6-7b67-411e1412678b	Product name	1	20140508
0ad8bdca-888e-00da-648b-6a4de854a167	Product name	1	20140508
433a3439-b8f3-d13a-d2c8-9b221d628d60	Product name	1	20140508
59212689-39e5-a976-6d21-882d76d8079a	Product name	1	20140508
7613b1a5-acb6-4e5e-6048-c44deeeb1212	Product name	1	20140508
78637fb0-95c8-441f-e4b4-db1274b6f956	Product name	1	20140508
df89bd47-2db4-d593-ab37-d11953fd5536	Product name	1	20140508
f151007d-265d-9fbe-857d-1d44f1cb76ba	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
10135-742-05	Bisoprolol Fumarate and Hydrochlorothiazide	500 in 1 BOTTLE	TABLET	500		4
10135-742-30	Bisoprolol Fumarate and Hydrochlorothiazide	30 in 1 BOTTLE	TABLET	30		4

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
10135-742-05	EA - Each	10135-742	66e511fe-5aea-4bbd-b266-8c755677719b	1	2022-06-06
10135-742-30	EA - Each	10135-742	eda2e5b5-f2ac-46bb-8c25-74366a929403	1	2022-06-06

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
10135-742	BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE TABLET [MARLEX PHARMACEUTICALS, INC.]	3	Current NDC, Legacy NDC, 2 package rows	20241004_df881501-42ae-624a-e053-2995a90ab2a0.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 3 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Bisoprolol Fumarate and Hydrochlorothiazide	BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE	ANI Pharmaceuticals, Inc.	a26bcf78-6515-4e9f-b2dc-4aaa8ec1a82c	2026-08-12	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 215562 application number: ANDA215562
Bisoprolol Fumarate and Hydrochlorothiazide	BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE	A-S Medication Solutions	90bb2207-2eaf-495b-a222-c69d4db9e7a3	2026-01-14	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 215562 application number: ANDA215562
Bisoprolol Fumarate and Hydrochlorothiazide	BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE	Marlex Pharmaceuticals, Inc.	df881501-42ae-624a-e053-2995a90ab2a0	2025-09-23	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 215562 application number: ANDA215562 ndc (product): 10135-742

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
UR59KN573L	BISOPROLOL FUMARATE	104344-23-2	BISOPROLOL FUMARATE
0J48LPH2TH	HYDROCHLOROTHIAZIDE	58-93-5	HYDROCHLOROTHIAZIDE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
854908	bisoprolol fumarate 10 MG / hydroCHLOROthiazide 6.25 MG Oral Tablet	PSN	df881501-42ae-624a-e053-2995a90ab2a0	4
854916	bisoprolol fumarate 2.5 MG / hydroCHLOROthiazide 6.25 MG Oral Tablet	PSN	df881501-42ae-624a-e053-2995a90ab2a0	4
854919	bisoprolol fumarate 5 MG / hydroCHLOROthiazide 6.25 MG Oral Tablet	PSN	df881501-42ae-624a-e053-2995a90ab2a0	4
854908	bisoprolol fumarate 10 MG / hydrochlorothiazide 6.25 MG Oral Tablet	SCD	df881501-42ae-624a-e053-2995a90ab2a0	4
854916	bisoprolol fumarate 2.5 MG / hydrochlorothiazide 6.25 MG Oral Tablet	SCD	df881501-42ae-624a-e053-2995a90ab2a0	4
854919	bisoprolol fumarate 5 MG / hydrochlorothiazide 6.25 MG Oral Tablet	SCD	df881501-42ae-624a-e053-2995a90ab2a0	4
854908	bisoprolol fumarate 10 MG / HCTZ 6.25 MG Oral Tablet	SY	df881501-42ae-624a-e053-2995a90ab2a0	4
854916	bisoprolol fumarate 2.5 MG / HCTZ 6.25 MG Oral Tablet	SY	df881501-42ae-624a-e053-2995a90ab2a0	4
854919	bisoprolol fumarate 5 MG / HCTZ 6.25 MG Oral Tablet	SY	df881501-42ae-624a-e053-2995a90ab2a0	4

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
10135-742-05	10135074205	500 TABLET in 1 BOTTLE (10135-742-05)	500 tablet	2022-05-01	0000-00-00	No	No	Current
10135-742-30	10135074230	30 TABLET in 1 BOTTLE (10135-742-30)	30 tablet	2022-05-01	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Bisoprolol Fumarate and Hydrochlorothiazide Tablets, USP Rx only	Marlex Pharmaceuticals, Inc.	2025-09-23	HUMAN PRESCRIPTION DRUG LABEL	4